Paul Mieyal

Paul Mieyal is a life sciences professional with a robust background in investing and transacting within the early-stage biotechnology, pharmaceutical, medical device, and diagnostic sectors. With a career spanning over two decades, Paul has gained expertise in venture capital, private equity, transaction negotiation, M&A, and IPOs. He has served as a public and private board representative, bringing in-depth experience in areas like capital raising, FDA product approval, strategic licensing, and investor relations. Paul's educational foundation includes a Doctor of Philosophy (Ph.D.) in Pharmacology from New York Medical College and a Bachelor of Arts (B.A.) in Chemistry and Psychology from Case Western Reserve University.